Clinical Trial Update: Safety Study of ORG 34517 for Major Depression With Psychotic Features [Phase 2]

View source ↗

Summary

A Phase 2 safety study evaluating ORG 34517 for major depressive disorder with psychotic features has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Psychotic Disorders

Drugs mentioned

• ORG 34517

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Major Depressive Disorder, Psychotic Disorders | Phase 2 | Status: COMPLETED